EFFECTS OF ATORVASTATIN AND MELATONIN ON GLYCEMIC CONTROL AND LIPID PROFILE IN TYPE 2 DIABETIC PATIENTS
Background: Dyslipidemia is a modifiable cardiovascular disease risk factor that remains largely uncontrolled in patients with type 2 diabetes mellitus. Administration of melatonin may improve tissue responses to insulin and increase the efficacy of drugs which act through this pathway like Sulfonyl...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Al-Nahrain University/College of medicine
2016-03-01
|
| シリーズ: | The Iraqi Journal of Medical Sciences |
| 主題: | |
| オンライン･アクセス: | https://iraqijms.com/index.php/jms/article/view/116 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|